Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62013TN0029

    Case T-29/13: Action brought on 17 January 2013 — AbbVie e.a. v EMA

    OJ C 79, 16.3.2013, p. 26–27 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    16.3.2013   

    EN

    Official Journal of the European Union

    C 79/26

    Action brought on 17 January 2013 — AbbVie e.a. v EMA

    (Case T-29/13)

    2013/C 79/46

    Language of the case: English

    Parties

    Applicants: AbbVie, Inc. (Wilmington, United States); and AbbVie Ltd (Maidenhead, United Kingdom) (represented by: P. Bogaert, G. Berrisch, lawyers, and B. Kelly, Solicitor)

    Defendant: European Medicines Agency

    Form of order sought

    The applicants claim that the Court should:

    —

    Annul the Decision of the European Medicines Agency EMA/685471/2012, of 5 November 2012, granting access to documents from the marketing authorisation dossier of a medical product; and

    —

    Order the European Medicines Agency to pay all costs in these proceedings, including the applicants’ costs.

    Pleas in law and main arguments

    The present action concerns a request for annulment under Article 263(4) TFEU of the Decision of the European Medicines Agency EMA/685471/2012, of 5 November 2012, granting access to documents from the marketing authorisation dossier of a medicinal product, pursuant to Regulation (EC) No 1049/2001 regarding public access to European Parliament, Council and Commission documents.

    In support of the action, the applicants rely on four pleas in law.

    1.

    First, the Decision violates Article 4(2) of the Transparency Regulation and the Applicants’ fundamental right to the protection of confidential commercial information.

    2.

    Second, the Decision violates the obligation to state reasons as regards the application of Article 4(2) of the Transparency Regulation.

    3.

    Third, the Decision violates the principle of legitimate expectations.

    4.

    Fourth, the Decision violates Directive No 2001/29/EC (1) on the harmonisation of certain aspects of copyright and related rights in the information society, of fundamental rights protecting property rights, including copyright and of the principles of proportionality and of good administration, insofar as access is granted by providing a copy of the documents.

    (1)  Directive 2001/29/EC of the European Parliament and of the Council of 22 May 2001 on the harmonisation of certain aspects of copyright and related rights in the information society

    Top